Karin, Nathan
Technion - Israel Institute of Technology,
Israel
2025 Rank: 37,671
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biotechnology
Rank in SubField 1: 724 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37,671 | 39,375 |
| Total Cites | 387 | 408 |
| H-index | 10 | 11 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 99 | 102 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 143 | 146 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 259 | 265 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 358 | 372 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
5.15%
|
|
Karin, Nathan
Technion - Israel Institute of Technology,
Israel
2024 Rank: 49,423
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biotechnology
Rank in SubField 1: 991 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49,423 | 56,584 |
| Total Cites | 349 | 364 |
| H-index | 10 | 10 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 87 | 87 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 135 | 137 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 234 | 236 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 322 | 334 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
4.12%
|
|
Karin, Nathan
Technion - Israel Institute of Technology,
Israel
2023 Rank: 36,752
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biotechnology
Rank in SubField 1: 835 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36,752 | 42,935 |
| Total Cites | 413 | 418 |
| H-index | 11 | 11 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 89 | 89 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 140 | 140 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 293 | 293 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 370 | 375 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.11 |
| Self-Citation Percentage |
1.20%
|
|
Karin, Nathan
Ruth & Bruce Rappaport Faculty of Medicine,
Israel
2022 Rank: 45,784
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biotechnology
Rank in SubField 1: 1,156 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45,784 | 46,805 |
| Total Cites | 340 | 379 |
| H-index | 11 | 11 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 59 | 63 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 107 | 113 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 244 | 258 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 299 | 324 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
10.29%
|
|
Karin, Nathan
The Ruth and Bruce Rappaport Faculty of Medicine,
Israel
2021 Rank: 61,910
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biotechnology
Rank in SubField 1: 1,417 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61,910 | 66,885 |
| Total Cites | 496 | 549 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 67 | 68 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 141 | 144 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 352 | 372 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 436 | 469 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
9.65%
|
|
Karin, Nathan
The Ruth and Bruce Rappaport Faculty of Medicine,
Israel
2020 Rank: 67,875
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biotechnology
Rank in SubField 1: 1,459 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67,875 | 80,199 |
| Total Cites | 342 | 356 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 49 | 49 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 92 | 92 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 248 | 248 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 299 | 313 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.14 |
| Self-Citation Percentage |
3.93%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.